SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-18-052641
Filing Date
2018-08-17
Accepted
2018-08-17 16:11:03
Documents
3
Period of Report
2018-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a18-19073_18ka.htm 8-K/A 26974
2 EX-99.1 a18-19073_1ex99d1.htm EX-99.1 427764
3 GRAPHIC g190731mm01i001.jpg GRAPHIC 2551
  Complete submission text file 0001104659-18-052641.txt   459647
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-13111 | Film No.: 181025895
SIC: 2834 Pharmaceutical Preparations